Eligo Bioscience
Eligo Bioscience is developing a new class of targeted biotherapeutic agents to selectively intervene on the microbiome. Eligo Bioscience uses proprietary methods in synthetic biology, protein and genome engineering to create Eligobiotics: genetic circuits packaged in phage-based delivery vectors used to diagnose, eradicate, or functionalize targeted microbial populations.